Related Experiment Video
Updated: Feb 18, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
Pancreatic Exocrine Insufficiency after Bariatric Surgery
Miroslav Vujasinovic1, Roberto Valente2,3, Anders Thorell4
1Center for Digestive Diseases, Karolinska University Hospital, SE-141 86 Stockholm, Sweden. miroslav.vujasinovic@sll.se.
Pancreatic exocrine insufficiency (PEI) is a common complication after bariatric surgery, often presenting with symptoms that mimic other gastric bypass issues. Early diagnosis and pancreatic enzyme replacement therapy are crucial for managing PEI in these patients.
Area of Science:
- Gastroenterology
- Bariatric Surgery
- Digestive Health
Background:
- Morbid obesity requires lifelong management, including post-bariatric surgery surveillance.
- Pancreatic exocrine insufficiency (PEI) is a potential complication of upper gastrointestinal surgery.
- The increasing number of bariatric procedures worldwide highlights the clinical significance of PEI.
Purpose of the Study:
- To investigate the occurrence and diagnostic challenges of PEI following bariatric surgery.
- To emphasize the importance of considering PEI in patients with persistent gastrointestinal symptoms post-surgery.
- To advocate for the inclusion of PEI management in the treatment algorithm for bariatric surgery patients.
Main Methods:
- Review of clinical presentations and diagnostic approaches for PEI after bariatric surgery.
- Discussion of symptom overlap between PEI and gastric bypass sequelae.
- Highlighting the utility of fecal elastase-1 (FE1) testing for PEI diagnosis.
Main Results:
- Symptoms like steatorrhea, weight loss, maldigestion, and malabsorption are common to both PEI and gastric bypass.
- Altered gastrointestinal anatomy post-surgery complicates PEI diagnosis.
- FE1 is identified as a valuable diagnostic tool for PEI.
Conclusions:
- PEI is a significant consideration in patients experiencing prolonged gastrointestinal complaints after bariatric surgery.
- Diagnostic difficulty arises from overlapping symptoms and altered anatomy.
- Pancreatic enzyme replacement therapy is recommended for confirmed PEI or suggestive symptoms.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Clinical Manifestations and Management
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
Cells and Secretions of the Pancreas
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...

